ArticleCancer cell international2024

CDK4/6 inhibition enhances T-cell immunotherapy on hepatocellular carcinoma cells by rejuvenating immunogenicity.

Xiurong Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.